Sex-Dependent Effects of Rivastigmine on Melatonin Receptors in Middle-Aged Rats. [PDF]
Noro Psikiyatr ArsÜnal NA +4 more
europepmc +1 more source
Effects of hydromethylthionine mesylate and rivastigmine in a pharmacological mouse model of Alzheimer's disease. [PDF]
Behav PharmacolRobinson L +5 more
europepmc +1 more source
Switching from Oral Cholinesterase Inhibitors to a Transdermal Donepezil Patch Attenuated Gastrointestinal Symptoms and Allowed Treatment Continuation in Three Patients with Alzheimer's Disease in Clinical Settings. [PDF]
Brain SciMotoi Y, Sanjo N.
europepmc +1 more source
Dynamic associations of cholinesterase inhibitors and memantine with cognitive trajectories in individuals with Alzheimer's or mixed dementia: a real-world analysis using the quality registry SveDem. [PDF]
Alzheimers Res TherChen C +5 more
europepmc +1 more source
When best practice is bad medicine: a new approach to rationing tertiary health services in South Africa. [PDF]
, 2008 Boulle, A, Ford, N, Kenyon, C
core +1 more source
Design and synthesis of new phosphazine and triazole derivatives for treatment of Alzheimer's disease: modulating ROS/JNK and Wnt/β-catenin signaling pathways. [PDF]
RSC AdvSalah RS +9 more
europepmc +1 more source
Pharmacokinetics of Double-Layer Patches With Microneedles Containing Procyclidine and Rivastigmine in Guinea Pigs. [PDF]
Basic Clin Pharmacol ToxicolMoon M +6 more
europepmc +1 more source
Cholinesterase inhibitors for patients with dementia: Patterns of prescribing and disparities in treatment. [PDF]
J Alzheimers DisHeo RJ +8 more
europepmc +1 more source
Antiglycative Properties of Anti-Dementia Drugs-In Vitro, In Silico Studies and a Systematic Literature Review. [PDF]
Antioxidants (Basel)Orlof W +5 more
europepmc +1 more source
The role of genetic polymorphisms on drug response in Alzheimer's disease: a systematic review. [PDF]
BMC Med GenomicsClimacosa FMM +12 more
europepmc +1 more source